Bilophila

Bilophila is studied because of its links to diet, sulfur metabolism, and gut inflammation. A stool result describes its abundance in your sample. Its use as a health marker remains exploratory: it hasn't been validated for diagnosing disease, predicting your cancer risk, or detecting inflammation before standard tests.

What This Result Measures

DNA sequencing estimates the relative abundance of Bilophila in stool. Relative abundance is its share of the bacteria identified in the sample. Bilophila is a genus, and Bilophila wadsworthia is its best-studied species. Studies identifying that species provide useful biological context, but a genus-level result does not establish which strains are present or what they are doing.

How These Bacteria Make a Living

Bilophila wadsworthia can live in the oxygen-poor environment of the colon and tolerate bile. Bile helps digest fat. Taurine is a sulfur-containing compound found in food and attached to some molecules in bile. The bacterium can use sulfur from taurine to produce hydrogen sulfide.

Mouse experiments have shown that B. wadsworthia can worsen intestinal inflammation and weaken the gut's protective barrier under particular conditions. Those findings help explain why researchers study it, but they don't establish that a higher stool result means your gut lining is being damaged. Abundance alone also doesn't measure hydrogen sulfide production.

Colorectal Polyps and Cancer

In a study of 780 people undergoing colonoscopy, Bilophila was more abundant in stool from people with adenomas than in those without polyps. Adenomas are growths that can develop into colorectal cancer. This was an exploratory comparison of people who already had different colonoscopy findings, so it couldn't establish whether Bilophila contributed to the polyps or changed in response to them.

A separate study followed roughly 48,000 men for 26 years. It examined a dietary score developed from foods associated with a community of sulfur-metabolizing bacteria, including B. wadsworthia. Men in the highest quarter of that score had about 43% higher risk of cancer in the distal colon or rectum than men in the lowest quarter, after adjustment for other risk factors. There was no clear association with cancer farther up the colon. This estimate applies to the dietary pattern; it cannot be assigned to your stool Bilophila result.

Heart and Metabolic Associations

In a cross-sectional study of 180 Spanish adults, higher stool Bilophila abundance was associated with measures of early vascular aging, including arterial stiffness. The study measured bacteria and vascular health at the same time. It did not show that Bilophila predicted a future heart attack or detected artery disease earlier than established tests.

Another study followed more than 90,000 adults for a median of 15 years and linked a higher sulfur microbial dietary score with higher all-cause and cancer mortality. It assessed diet without directly measuring each person's Bilophila abundance, so it provides indirect evidence about dietary patterns and microbial communities.

There is also a proposed connection to TMAO. Your liver can make TMAO from trimethylamine produced by gut microbes, and higher blood TMAO has been associated with cardiovascular disease. Analysis of bacterial genomes and gene activity suggests that Bilophila may consume trimethylamine through an alternative pathway. Whether this lowers blood TMAO or prevents cardiovascular disease in people remains unproven.

An exploratory Mendelian randomization study also suggested a link between genetically predicted B. wadsworthia abundance and lower TMAO. This approach uses inherited human genetic differences to investigate possible causal relationships. Its findings depend on assumptions about those genetic differences and are not equivalent to changing the bacterium experimentally. The study does not establish a protective effect of a higher stool Bilophila result.

Brain, Mood, and Other Disease Associations

A small Chinese study found more B. wadsworthia in stool from people with Parkinson's disease than from their healthy spouses. A 2026 study combining stool profiling with brain MRI in two population cohorts linked higher Bilophila, with supporting species-level analyses of B. wadsworthia, to smaller volumes in parts of the brain involved in movement and motivation. These were associations, not proof that the bacterium caused brain changes.

Higher stool Bilophila has also been reported in studies of major depressive disorder, active Behçet's disease, and symptomatic hand osteoarthritis. The osteoarthritis study included nearly 1,400 adults. These findings do not make Bilophila a diagnostic or monitoring test for those conditions.

In women with a history of diverticulitis, a study found altered relationships between stool B. wadsworthia and bile acids. In a small study of chronic HIV infection, Bilophila was detected only in the uninfected comparison group. These findings concern particular study populations and do not establish a consistent disease-specific pattern.

What a Trend Can Show

Repeated stool studies often find larger differences between people than within one person over a short period. That supports using a sample to describe a microbial community at a particular time, but it doesn't guarantee that an individual Bilophila measurement will stay stable. A rising or falling result has no validated meaning for future disease risk.

When Results Can Be Misleading

A percentage can rise because other bacteria have declined, even if the absolute amount of Bilophila hasn't increased. DNA detection also doesn't measure whether the bacteria are alive, how much gas they produce, or whether they are affecting the gut lining. Stool samples describe the material passed in a bowel movement and do not directly sample every part of the intestine.

Collection, storage, DNA extraction, sequencing, and the software used to identify bacteria can affect the result. Differences between laboratory methods can look like biological changes. A result below the detection limit also does not prove that the organism is absent.

Recent changes in diet, antibiotics, bowel-cleansing preparations, and changes in bowel habits can affect the sample. These can be real changes in the microbial community without showing that a disease has developed or improved. Medication-associated changes need to be interpreted in the context of the condition being treated.